Epilepsia
-
Randomized Controlled Trial Clinical Trial
Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
To evaluate the safety and efficacy of high dose gabapentin (GBP) monotherapy (3,000-4,800 mg/day) in patients with medically refractory partial epilepsy. ⋯ GBP monotherapy is well tolerated in daily doses of up to 4,800 mg and is effective in a subgroup of patients with medically refractory partial epilepsy.